. The Case for Using Actigraphy Generated Sleep and Activity Endpoints in Alzheimer's Disease Clinical Trials. J Prev Alzheimers Dis. 2016;3(3):173-176. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.